Let’s Talk Seizures
DTC & HCP Prelaunch for VALTOCO (diazepam nasal spray) at Neurelis
Imagine living under the constant threat of a lightening strike with nothing on hand for protection. For many people with epilepsy, that’s what it’s like living with the threat of breakthrough seizures, even when taking preventive anti-epileptic drugs.
The unpredictability of where and when a seizure might strike can be the worst part of epilepsy. And it takes a serious toll. Without a simple on-hand rescue treatment to stop a seizure after it starts, many people with epilepsy stay home and limit their activities. Many also have depression (up to 35%) or an anxiety disorder (10% to 15%).
To raise awareness of the unmet medical need and get patients, care partners, and health care providers talking about it, we created Let’s Talk Seizures.
Let’s Talk Seizures spotlights the negative impact of unpredictable seizures with its rallying cry, “A Seizure Can Turn Your World Upside Down.” Its double silhouette of a family outing before and after a seizure strikes is powerfully evocative. It captures the suddenness of onset and how instantly a good day flips into a very bad one. In market research, patients were deeply moved by it.
Neurelis launched VALTOCO, an immediate-use seizure medicine made with a technology that increases drug absorption across the nasal mucosa. Pocket-sized and ready-to-use, VALTOCO puts the power to stop a seizure in the hands of patients and their family members, friends, and coworkers.
With VALTOCO, people with epilepsy at last have a way to alleviate their dread of the “upside-down world” of breakthrough seizures.